Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by princeofcuton Apr 24, 2015 3:53pm
136 Views
Post# 23662525

RE:RE:RE:News Release Next Week?

RE:RE:RE:News Release Next Week?ROTFLMAO..so leftcoast got exposed twice in one post as a fraudster..last Q ended on Jan 31, 2015 as best i can tell looking at the last Q report and so going way out a 208 limb i'm betting this Q ends April 30, 2015 which would be consistent when last year in 2014 it also ended on April 30...but i bet April 30 comes and goes and no ODD it will be classed as just more DMspeak (if you know what i mean) consistent with confusing ODD trials and some huge cardio trial and...well i could go on..ROTFLMAO..no comedy today and BTI not trading i wonder how much trading activity the three stooges generate between them, is that one of the services they provide, trading volume cause it sure looks suspicious to me
Bullboard Posts